Vaxdyn — Grant · €2.5M

The Seville-based vaccine biotech secured €14.5M from the European Commission's EIC Accelerator to take its multi-pathogen vaccine platform against antibiotic-resistant bacteria into the clinic. The package is blended finance: €2.5M in non-dilutive grant plus €12M in equity from the EIC Fund, awarded among 68 selected projects out of 969 applicants.